From: Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians
Panel A. Association studies results | ||||||||
---|---|---|---|---|---|---|---|---|
Population | aSNP | Position (GRCh37) | Alleles (M/m) | Genea | MAFb | OR (95%C.I.) | P | |
PanScan + PanC4c | rs12998719 | 2:67583252 | G/A | – | 29% | 1.11 (1.05–1.16) | 5.51 × 10–5 | |
PANDoRAc | rs12998719 | 2:67583252 | G/A | – | 28% | 1.05 (0.95–1.15) | 0.38 | |
FinnGen | rs113955626 | 3:23107748 | C/T | – | 7% | 1.35 (1.17–1.55) | 4.79 × 10–5 | |
JaPAN | rs117585753 | 10:25190572 | C/T | PRTFDC1 | 10% | 1.35 (1.19–1.54) | 3.59 × 10–6 |
Panel B. Top SNP population-based frequency | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Population | aSNP | Position (GRCh37) | Alleles (M/m) | 1000G MAF | gnomAD MAF | HGDPd | |||||
EUR | FIN | EAS (%) | EUR (%) | FIN | EAS (%) | EUR (%) | EAS | ||||
PanScan + PanC4c | rs12998719 | 2:67583252 | G/A | 27% | 30% | 43 | 36 | 29% | 42 | 25 | 35% |
FinnGen | rs113955626 | 3:23107748 | C/T | 4% | 4% | 13 | 5 | 8% | 14 | 8 | 18% |
JaPAN | rs117585753 | 10:25190572 | C/T | 8‰ | 5‰ | 10 | 1 | 3‰ | 9 | 1 | 8% |